Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 103Carcinoma, Renal Cell 30Urinary Bladder Neoplasms 22Breast Neoplasms 20Lung Neoplasms 10Carcinoma, Transitional Cell 10Neoplasms 8Melanoma 8Kidney Neoplasms 8Neoplasm Metastasis 7Colonic Neoplasms 7Pancreatic Neoplasms 6Ovarian Neoplasms 6Metastatic Castration-resistant Prostate Cancer 6Sarcoma 5Head and Neck Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Brain Neoplasms 4Diabetes Mellitus 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Urologic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Rectal Neoplasms 2Prostatic Hyperplasia 2Prostate Cancer Castration-resistant Prostate Cancer 2Osteosarcoma 2

Interventions

Creatine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Sedentary Behavior × Genitourinary × Clear all
NCT03987217 2025-05-14

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

University of Utah

Phase EARLY_PHASE1 Completed
73 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms, Sedentary Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡